289 related articles for article (PubMed ID: 33681221)
1. CD73 Ectonucleotidase Restrains CD8+ T Cell Metabolic Fitness and Anti-tumoral Activity.
Briceño P; Rivas-Yañez E; Rosemblatt MV; Parra-Tello B; Farías P; Vargas L; Simon V; Cárdenas C; Lladser A; Salazar-Onfray F; Elorza AA; Rosemblatt M; Bono MR; Sauma D
Front Cell Dev Biol; 2021; 9():638037. PubMed ID: 33681221
[TBL] [Abstract][Full Text] [Related]
2. CD73-mediated adenosine production promotes stem cell-like properties in mouse Tc17 cells.
Flores-Santibáñez F; Fernández D; Meza D; Tejón G; Vargas L; Varela-Nallar L; Arredondo S; Guixé V; Rosemblatt M; Bono MR; Sauma D
Immunology; 2015 Dec; 146(4):582-94. PubMed ID: 26331349
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate up-regulates ecto-5'-nucleotidase/CD73 and reduces the frequency of T lymphocytes in the glioblastoma microenvironment.
Figueiró F; de Oliveira CP; Bergamin LS; Rockenbach L; Mendes FB; Jandrey EH; Moritz CE; Pettenuzzo LF; Sévigny J; Guterres SS; Pohlmann AR; Battastini AM
Purinergic Signal; 2016 Jun; 12(2):303-12. PubMed ID: 26910734
[TBL] [Abstract][Full Text] [Related]
4. Enhanced expression of CD39 and CD73 on T cells in the regulation of anti-tumor immune responses.
Shevchenko I; Mathes A; Groth C; Karakhanova S; Müller V; Utikal J; Werner J; Bazhin AV; Umansky V
Oncoimmunology; 2020 Apr; 9(1):1744946. PubMed ID: 33457090
[TBL] [Abstract][Full Text] [Related]
5. Defining the CD39/CD73 Axis in SARS-CoV-2 Infection: The CD73
Ahmadi P; Hartjen P; Kohsar M; Kummer S; Schmiedel S; Bockmann JH; Fathi A; Huber S; Haag F; Schulze Zur Wiesch J
Cells; 2020 Jul; 9(8):. PubMed ID: 32707842
[TBL] [Abstract][Full Text] [Related]
6. Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbs.
Allard B; Pommey S; Smyth MJ; Stagg J
Clin Cancer Res; 2013 Oct; 19(20):5626-35. PubMed ID: 23983257
[TBL] [Abstract][Full Text] [Related]
7. Decreased frequency of CD73+CD8+ T cells of HIV-infected patients correlates with immune activation and T cell exhaustion.
Tóth I; Le AQ; Hartjen P; Thomssen A; Matzat V; Lehmann C; Scheurich C; Beisel C; Busch P; Degen O; Lohse AW; Eiermann T; Fätkenheuer G; Meyer-Olson D; Bockhorn M; Hauber J; van Lunzen J; Schulze Zur Wiesch J
J Leukoc Biol; 2013 Oct; 94(4):551-61. PubMed ID: 23709688
[TBL] [Abstract][Full Text] [Related]
8. Adenosine and the adenosine A2A receptor agonist, CGS21680, upregulate CD39 and CD73 expression through E2F-1 and CREB in regulatory T cells isolated from septic mice.
Bao R; Shui X; Hou J; Li J; Deng X; Zhu X; Yang T
Int J Mol Med; 2016 Sep; 38(3):969-75. PubMed ID: 27430240
[TBL] [Abstract][Full Text] [Related]
9. CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression.
Bono MR; Fernández D; Flores-Santibáñez F; Rosemblatt M; Sauma D
FEBS Lett; 2015 Nov; 589(22):3454-60. PubMed ID: 26226423
[TBL] [Abstract][Full Text] [Related]
10. Extracellular purine metabolism and signaling of CD73-derived adenosine in murine Treg and Teff cells.
Romio M; Reinbeck B; Bongardt S; Hüls S; Burghoff S; Schrader J
Am J Physiol Cell Physiol; 2011 Aug; 301(2):C530-9. PubMed ID: 21593451
[TBL] [Abstract][Full Text] [Related]
11. Elevated ATP via enhanced miRNA-30b, 30c, and 30e downregulates the expression of CD73 in CD8+ T cells of HIV-infected individuals.
Shahbaz S; Okoye I; Blevins G; Elahi S
PLoS Pathog; 2022 Mar; 18(3):e1010378. PubMed ID: 35325005
[TBL] [Abstract][Full Text] [Related]
12. Preventing ATP Degradation by ASO-Mediated Knockdown of CD39 and CD73 Results in A2aR-Independent Rescue of T Cell Proliferation.
Festag J; Thelemann T; Schell M; Raith S; Michel S; Jaschinski F; Klar R
Mol Ther Nucleic Acids; 2020 Sep; 21():656-669. PubMed ID: 32739778
[TBL] [Abstract][Full Text] [Related]
13. Inversed Ratio of CD39/CD73 Expression on γδ T Cells in HIV Versus Healthy Controls Correlates With Immune Activation and Disease Progression.
Kolbe K; Wittner M; Hartjen P; Hüfner AD; Degen O; Ackermann C; Cords L; Stellbrink HJ; Haag F; Schulze Zur Wiesch J
Front Immunol; 2022; 13():867167. PubMed ID: 35529864
[TBL] [Abstract][Full Text] [Related]
14. Autocrine Adenosine Regulates Tumor Polyfunctional CD73
Gourdin N; Bossennec M; Rodriguez C; Vigano S; Machon C; Jandus C; Bauché D; Faget J; Durand I; Chopin N; Tredan O; Marie JC; Dubois B; Guitton J; Romero P; Caux C; Ménétrier-Caux C
Cancer Res; 2018 Jul; 78(13):3604-3618. PubMed ID: 29559470
[TBL] [Abstract][Full Text] [Related]
15. Extracellular adenosine metabolism in immune cells in melanoma.
Umansky V; Shevchenko I; Bazhin AV; Utikal J
Cancer Immunol Immunother; 2014 Oct; 63(10):1073-80. PubMed ID: 24756420
[TBL] [Abstract][Full Text] [Related]
16. CD73 on T Cells Orchestrates Cardiac Wound Healing After Myocardial Infarction by Purinergic Metabolic Reprogramming.
Borg N; Alter C; Görldt N; Jacoby C; Ding Z; Steckel B; Quast C; Bönner F; Friebe D; Temme S; Flögel U; Schrader J
Circulation; 2017 Jul; 136(3):297-313. PubMed ID: 28432149
[TBL] [Abstract][Full Text] [Related]
17. Ectonucleotidase-Mediated Suppression of Lupus Autoimmunity and Vascular Dysfunction.
Knight JS; Mazza LF; Yalavarthi S; Sule G; Ali RA; Hodgin JB; Kanthi Y; Pinsky DJ
Front Immunol; 2018; 9():1322. PubMed ID: 29942314
[TBL] [Abstract][Full Text] [Related]
18. IL-21 promotes the development of a CD73-positive Vγ9Vδ2 T cell regulatory population.
Barjon C; Michaud HA; Fages A; Dejou C; Zampieri A; They L; Gennetier A; Sanchez F; Gros L; Eliaou JF; Bonnefoy N; Lafont V
Oncoimmunology; 2017; 7(1):e1379642. PubMed ID: 29296543
[TBL] [Abstract][Full Text] [Related]
19. Ecto-5'-Nucleotidase (CD73) Regulates the Survival of CD8+ T Cells.
Rosemblatt MV; Parra-Tello B; Briceño P; Rivas-Yáñez E; Tucer S; Saavedra-Almarza J; Hörmann P; Martínez BA; Lladser Á; Rosemblatt M; Cekic C; Bono MR; Sauma D
Front Cell Dev Biol; 2021; 9():647058. PubMed ID: 33928082
[TBL] [Abstract][Full Text] [Related]
20. Ectonucleotidase Expression on Human Amnion Epithelial Cells: Adenosinergic Pathways and Dichotomic Effects on Immune Effector Cell Populations.
Morandi F; Horenstein AL; Quarona V; Faini AC; Castella B; Srinivasan RC; Strom SC; Malavasi F; Gramignoli R
J Immunol; 2019 Feb; 202(3):724-735. PubMed ID: 30587530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
